Aptorum Group Limited (APM)

GB — Healthcare Sector
Peers: ADXN  SNGX  ATXI  ADIL  ATHE  ARDS  OXBR  HOTH 

Automate Your Wheel Strategy on APM

With Tiblio's Option Bot, you can configure your own wheel strategy including APM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol APM
  • Rev/Share 0.0
  • Book/Share 2.3493
  • PB 0.458
  • Debt/Equity 0.1492
  • CurrentRatio 1.1652
  • ROIC -0.238

 

  • MktCap 13256887.0
  • FreeCF/Share 0.0
  • PFCF 0.0
  • PE -2.4313
  • Debt/Assets 0.1909
  • DivYield 0
  • ROE -0.1884

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 3
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Why Is Nano-Cap Aptorum Stock Rallying On Thursday?
APM
Published: August 21, 2025 by: Benzinga
Sentiment: Positive

Aptorum shares trade higher on 168.16 million volume vs 3.25 million average. DiamiR gains CLEP approval for APOE Genotyping test in New York.

Read More
image for news Why Is Nano-Cap Aptorum Stock Rallying On Thursday?
Andean Precious Metals Corp. (ANPMF) Q2 2025 Earnings Call Transcript
ANPMF, APM
Published: August 13, 2025 by: Seeking Alpha
Sentiment: Neutral

Andean Precious Metals Corp. (OTCQX:ANPMF) Q2 2025 Earnings Conference Call August 13, 2025 9:00 AM ET Company Participants Alberto Morales - Founder, CEO & Executive Chairman Amanda Mallough - Corporate Participant Dom Kizek - Corporate Participant Juan Carlos Sandoval - Chief Financial Officer Yohann Bouchard - President & Director Conference Call Participants Allison Carson - Desjardins Securities Inc., Research Division Ben Pirie - Atrium Research Corporation Justin Chan - SCP Resource Finance LP, Research Division Operator Good morning, and welcome to Andean Precious Metals Second Quarter 2025 Results Conference Call. As a remainder, all participants are in the listen-only-mode.

Read More
image for news Andean Precious Metals Corp. (ANPMF) Q2 2025 Earnings Call Transcript

About Aptorum Group Limited (APM)

  • IPO Date 2018-12-18
  • Website https://www.aptorumgroup.com
  • Industry Biotechnology
  • CEO Chung Yuen Huen
  • Employees 1
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.